title: Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance.
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Monica
authors.initials: M
authors.lastname: Bocchia
authors.forename: Laura
authors.initials: L
authors.lastname: Cannella
authors.forename: Marzia
authors.initials: M
authors.lastname: Defina
authors.forename: Micaela
authors.initials: M
authors.lastname: Ippoliti
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Loglisci
authors.forename: Michelina
authors.initials: M
authors.lastname: Santopietro
authors.forename: Francesco
authors.initials: F
authors.lastname: Lauria
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena